Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Cancers × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 50 Prostatic Neoplasms 39 Neoplasms 39 Breast Neoplasms 35 Neoplasm Metastasis 18 Lung Neoplasms 17 Unspecified Adult Solid Tumor, Protocol Specific 15 Ovarian Neoplasms 14 Head and Neck Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 13 Advanced Solid Tumors 10 Stomach Neoplasms 9 Pancreatic Neoplasms 9 Urinary Bladder Neoplasms 8 Solid Tumor 8 Sarcoma 8 Melanoma 8 Fallopian Tube Neoplasms 7 Esophageal Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Small Cell Lung Carcinoma 6 Salivary Gland Neoplasms 6 Colorectal Neoplasms 6 Esophageal Squamous Cell Carcinoma 5 Carcinoma, Renal Cell 5 Breast Neoplasms, Male 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Esthesioneuroblastoma, Olfactory 4 Endometrial Neoplasms 4

Interventions

pembrolizumab 1 Sirolimus 1 Nivolumab 1 Ipilimumab 1 Docetaxel 1 Albumin-Bound Paclitaxel 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01019941 2010-12-16

126ASC08Q

Chong Kun Dang Pharmaceutical

Phase 1 Completed

Advanced Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡